Download - Table of Contents - Vertu Medical Technologiesvertumedicaltechnologies.com/wp-content/uploads/... · Proof of market size: Global Surgical Equipment Market was valued at $9,783.8

Pag

e1

Pag

e2

Table of Contents

1. SURGICAL INSTRUMENT TECHNOLOGIES…………………..... 3

2. CRITICAL CARE OXYGEN SATURATION DETECTION

DEVICES………………………………………………………………….. 6

3. AIRWAY MANAGEMENT TECHNOLOGIES…………………….. 9

4. PREVENTION OF SUDDEN CARDIAC DEATH IN

ATHLETES………………………………………………………………. 11

5. REVOLUTIONARY SUMMATION EKG TECHNOLOGIES….... 13

6. VARIABLE FREQUENCY UV LIGHT STERILIZATION………. 15

7. SUMMATION TECHNOLOGIES APPLIED TO PHYSIOLOGIC

DATA DETECTION…………………………………………………….. 17

8. FEMININE HYGIENE TECHNOLOGIES………………………..... 18

9. BIOPHASIC SENSORY STIMULATION TECHNOLOGIES……. 20

10. INFANT ENVIRONMENT TECHNOLOGIES……………………21

Pag

e3

1. SURGICAL INSTRUMENT TECHNOLOGIES

BRIEF ABSTRACT:

Benefits: Allows ambidextrous surgical instrument use, introduces

ambidextrous surgical technique training, and reduces surgical errors.

Both right and left-handed surgeons can operate more efficiently.

Reduces cost of purchasing multiple sets of surgical instruments.

Technology: Proprietary, patent pending locking mechanism and

design.

Market Impact: Estimate $250 million per year

Industry Insights:

CLICK HERE TO VIEW VMT SURGICAL INSTRUMENT VIDEO

https://www.youtube.com/watch?v=vnktKt2y2Rs&feature=youtu.be

https://www.youtube.com/watch?v=vnktKt2y2Rs&feature=youtu.be

Pag

e4

Proof of market size: Global Surgical Equipment Market was valued

at $9,783.8 million in 2016 and is expected to reach $15,737.1 million

by 2023 supported by a CAGR of 7.0% during the forecast period

2017 to 2023. Surgical equipment are the medical devices used to cut,

coagulate, desiccate, and fulgurate the body tissues during the surgical

procedures.

(Source: https://www.alliedmarketresearch.com/surgical-equipment-market)

Development Stage: Engineered, tested, ready for market

Time to Market: 12 - 18 months

EXPANDED ABSTRACT:

Vertu Medical will soon be a disruptor in the surgical instrument arena with the

introduction of our revolutionary new surgical instruments design and

technologies. Vertu Medical has solved the Gordian Knot impasse of centuries old

surgical instrument designs; laden with inherent design flaws, that have proven to

have unintentional negative consequences to patients. A primary example of

conventional surgical instrument design flaws is that of the locking mechanism.

Those instruments that require locking mechanisms are right hand biased to the

degree that left-handed medical students are often dissuaded from applying for

surgical residency positions. Additionally, even right-hand dominant surgeons are

often forced to disengage locked surgical instruments with the left hand when they

are performing emergency interventions or being positioned across the surgical

table, even in a controlled setting, assuming the role of assistant surgeon. This

unorthodox disengagement of the conventional locking mechanisms has proven too

often to damage delicate tissues or structures of the patient or animal undergoing a

surgical procedure.

Over the past fifty years or so, as technology advanced, many attempts have been

made to provide viable solutions to the right-hand biased locking mechanisms

which have resulted in alternative configurations that simply have not nor will not

ever be adopted in the surgical instrument arena. Often these attempts have

mandated additional attachments to the instrument, additional maneuvers required

to reverse the locking mechanism components or designs so cumbersome that the

instrument itself would probably pose a danger to delicate structures. Simply put, a

surgeon is not going to use any new instrument design that significantly looks

different from what he or she has been trained with or requires additional

maneuvers to achieve the same function. Also, with healthcare cost constraints

being as they are, surgical companies would not be able to compete by

manufacturing surgical instruments with additional components that would require

Pag

e5

additional manufacturing equipment and assembly labor. More so, even a single

case of a lost component, from those attempted designs requiring them, left inside

a patient would legally devastate the company that produced it. Also, the FDA in

the United States has yet to approve any of these alternative versions.

Vertu Medical Technologies took on this century old surgical instrument locking

mechanism problem and did what has been said to be impossible. Vertu’s novel medical

instrument designs coupled with the means and methods provided offer several distinct

advantages over current and prior art. One improvement, utilizing the provided design of

inventor’s surgical and medical instrument releasable locking device, for those

instruments requiring such components, provides a permanently attached, rigid, durable

locking device that is vertically oriented thereby permitting an identical left and right

handed surgical technique to engage or disengage the locking mechanism of the device.

Our petitioned solution provides an improved ergonomic design and locking section

serving to replace the existing instrument handle section and locking sections of those

surgical and medical instruments that function with pivotally connected angular lever

arms that scissors to open and close a gripping section. The improved horizontally

oriented releasable locking device section provided allows an ambidextrous user means

for engaging and disengaging the locking devices with identical surgically trained

technique whether user’s left or right hand is being utilized. The invention’s novel design

grants the surgical and medical instrument industry a universally designed instrument and

locking device applicable to any and all medical and surgical instruments requiring such

a locking component for applicable function, capable of performing traditional and

ambidextrous utility.

Our ‘Open Loop’ patent petitioned designs provide for an absolute ambidextrous right or

left hand engaging and disengaging function that is undetectable to a surgeon. Simply

put, a surgeon given our instrument designs, being behind a poster board obstructing his

or her view, would engage and disengage the locking mechanism with the exact same

maneuvers of the right or left hand and sense absolutely no difference from that in current

use.

This breakthrough solution that Vertu Medical Technologies now provides will serve to

prevent the unintentional harm to delicate structures due to unorthodox opening and

closing current available surgical instruments, being right hand biased, with the left hand.

Additionally, surgical residents will soon be able to use our technology to train

ambidextrously during medical school and residency training and carry the dexterity into

private practice. Most importantly, the reduction in harm to delicate structures logically

will result in future medical liability from using outdated standard conventional

instrument designs. It is our intention to dominate the twenty-billion-dollar yearly

surgical instrument market with licensing and or manufacturing applications.

During the interval past three years our petitioned “Open Loop Technology”

reconfiguration has undergone the scrutiny of finite element analysis for material

stressors as well as continuous repetitive engagement and disengagement of our

revolutionary locking mechanism nonstop without a single failure.

Pag

e6

2. CRITICAL CARE OXYGEN SATURATION DETECTION

DEVICES

BRIEF ABSTRACT:

Benefits: Allows rapid oxygen saturation determinations in critical patient

presentations where conventional pulse oximetry fails. Precludes more invasive

tests from preventing critical care patients from receiving necessary interventions.

Significantly increases the time for determining crucial vital sign information in

hemodynamically compromised patients. Reduces healthcare cost in critical care

settings.

Technology: Proprietary, patent pending technology providing temporary

enhanced microcirculation in the hemodynamically compromised patient thus

permitting accurate oxygen saturation determinations.


Pag

e7

Industry Insights: Global Pulse Oximeters Market is expected to reach $1.901

billion by 2022, supported by a CAGR of 6.3% during the forecast period 2016 -

2022. The demand for pulse oximeters is expected to increase in the near future,

owing to efficient diagnosis of critical health conditions and ability to track the

health status of patients in home settings.

The global pulse oximeters market is driven by factors such as rise in incidence of

chronic diseases and surge in geriatric population. Moreover, increase in healthcare

expenditure in the emerging economies and high demand for proactive monitoring

are expected to unleash new opportunities for market players.

Development Stage: Engineered, tested, ready for market

Time to Market: 12 - 18 months

EXPANDED ABSTRACT:

Oxygenation occurs when oxygen molecules (O2) enter the tissues of the body. For

example, blood is oxygenated in the lungs, where the oxygen molecules travel

from the air and then into the blood. In medical terminology, oxygenation is

commonly used to refer to oxygen saturation. Again, in medical common use

oxygen saturation (SO2) is commonly referred to as “sats”, which is the

measurement of the percentage of hemoglobin binding sites in the bloodstream

occupied by oxygen.

A Pulse Oximeter is a device that relies on the light absorption characteristics of

saturated hemoglobin to give an indication of oxygen saturation, calculates the

peripheral oxygen saturation of a person and indirectly monitors the oxygen

saturation of a person or patient’s blood without having to take a direct sample

from the blood. The oxygen saturation changes with blood volume in the skin and

the pulse oximeter device is often attached to medical monitors so staff personnel

can always see a patient’s oxygenation. The intermittent or continuous evaluation

of a patient’s oxygenation is a crucial asset in determining the patient’s need for

oxygen supplementation and whether a patient is improving or worsening during

their treatment regarding sufficiently oxygenating tissues. Portable pulse oximeters

are available for home monitoring of blood oxygen. Home pulse oximeters are

typically used to monitor the respiratory status of patients with advanced lung or

heart pathology or to detect sleep apnea in the infant, for example. The

documentation of a patient’s O2 saturation is now considered the fifth vital sign

added commonly in clinic and hospital settings to a patient’s blood pressure, pulse,

Pag

e8

temperature and respiratory rate. The pulse oximeter has had wide adoption in the

United States since the late 1980’s.

A pulse oximeter is useful in any setting where a patient’s oxygenation is unstable,

including intensive care, operating, recovery, emergency and hospital ward

settings, pilots in unpressurized aircraft, for assessment of any patient’s

oxygenation, and for determining the effectiveness of or need for supplemental

oxygen. Assessing a patient’s need for oxygen is the most essential element to life;

no human life thrives in the absence of oxygen and therefore we establish medical

algorithms for serious medical presentations, assessing the airway and breathing

before any other parameter is inspected.

Because of their simplicity and speed, pulse oximeters are of critical importance in

emergency medicine and are also very useful for patients with advanced cardiac or

respiratory disease, especially COPD or CHF, and as mentioned to facilitate

diagnosis of sleep apnea and hypoventilation during sleep.

Having briefly discussed the mechanism and manner of the common use of pulse

oximetry we must consider those medical situations whereby pulse oximetry

readings are jeopardized and negatively affected. In the hypothermic patient the

patient’s peripheral blood flow has been constricted to protect the vital structures

and organs through enhanced macrocirculation. The diversion of peripheral blood

flow, changes in local PH and temperature effects on the oxygenation dissociation

curve also negatively affect the ability of pulse oximetry to accurately measure

oxygen saturation. Another situation negatively affecting pulse oximetry readings

is any condition causing shock in a patient. In this situation, the blood flow volume

is reduced peripherally, and the resulting acidosis and temperature changes

negatively affect the accuracy of pulse oximetry readings. Yet another medical

presentation with adverse effects on pulse oximetry is a patient in respiratory

extremis with the inability to adequately oxygenate the blood from peripheral

circulatory collapse, direct hypoventilation restricting phenomenon, or cardiac

compromise as with acute myocardial infarction or cardiac decompensation from

congestive heart failure, all adversely affecting oximetry readings with common

device application.

Vertu Medical addressed these, and other clinical presentations where pulse

oximetry readings are compromised and solved the problem in each, and every

example stated here. Through our patent petitioned breakthrough technologies in

pulse oximetry detection and readings, significantly enhanced patient oxygen

saturation monitoring can be provided to the patient presentations where

conventional pulse oximeters fail to obtain valid results. Our technologies will save

lives in the acute setting as well as save considerable health care expenses by

avoiding the need for more invasive procedures providing the same results as non-

invasive pulse oximetry.

Pag

e9

3. AIRWAY MANAGEMENT TECHNOLOGIES

BRIEF ABSTRACT:

Benefits: Improves endotracheal tube inserting precision, tube stabilization and

airway management to reduce errors, obtains vital physiological data, improves

patient outcomes, and minimize damage from intubation.

Technology: Proprietary, patent pending technology and system that facilitates

correct endotracheal tube placement, provides rapid and secure tube stabilization,

provides circuitry and software to interpret critical physiological parameters that is

transmittable through a responsive networked support system.


Industry Insights:

Pag

e10

The global airway management devices market size was valued at USD 1.1 billion

in 2016 and is expected to grow at a CAGR of 7.6% during the forecast period.

The increasing prevalence of respiratory diseases is predicted to be one of the high

impact rendering drivers of this market. According to the WHO estimates, 65

million people suffer from moderate-to-severe COPD. Moreover, COPD is

predicted to be the third leading cause of death worldwide.

This high prevalence coupled with increase in anesthesia usage, due to increase in

surgeries, is expected to propel the demand for advanced devices, thus, exerting a

positive impact on the overall market growth. The increasing need of emergency

treatment for prolonged illnesses as well as protracted treatments associated with

lung diseases in children and adults is expected to drive the market growth.

Development Stage: Concepted, designed, prototype stage, not tested

Time to Market: 36-60 months

EXPANDED ABSTRACT:

Methods and devices are provided for, but not limited to; perform airway

intubation of mammals. In practicing the subject methods, trained individuals are

provided significantly improved methods and devices to intubate the airway of a

mammal, secure the endotracheal tube components provided to a mammal’s

perioral region utilizing unique gripping components, verify correct anatomical

placement of endotracheal tube components, provide supplementary ventilation for

a mammal in a non-interfering manner, and gather and analyze pertinent

physiological data from the mammal. Additionally, methods and devices are

provided for trained personnel to investigate, intervene and alter specific

conditions identified through present invention’s integrated system and provide

continuous and or interrupted monitoring of specific mammal physiological

parameters in a multitude of settings. Provided elastomeric circuitry permits

software and hardware to acquire and analyze gathered physiological data from an

intubated mammal. Present invention will be shown to significantly remediate a

multitude of prior art’s inabilities and complications well known to the medical

industry and significantly expand the scope of endotracheal tubes.

Pag

e11

4. PREVENTION OF SUDDEN CARDIAC DEATH IN ATHLETES

BRIEF ABSTRACT:

Benefits: Allows for rapid static and real time evaluations of an athlete’s heart

electrical signals and physiological structure in the form similar to conventional

cardiogram, X Ray and Echocardiogram. A.I. determined thresholds determine if

the athlete is within the safe zone or potentially susceptible to an undesirable

cardiac event.

Technology: Proprietary, patent pending monitoring system, software, and

communication protocol.


Industry Insights:

Pag

e12

The cardiology market consists of cardiac assist devices, cardiac prosthetic

devices, cardiac rhythm management (CRM), cardiovascular monitoring and

diagnostic devices, cardiovascular surgical devices, electrophysiology, and

interventional cardiology.

With its $54.2 billion market opportunity by 2020, cardiology presents an attractive

target for non-traditional MedTech players—if they can offer high-impact solutions

supported by credible evidence has the potential to disrupt traditional clinical

research models.

Development Stage: Conceptual


EXPANDED ABSTRACT:

Methods and devices to facilitate identification of cardiac abnormalities are

provided for, but not limited to, individuals seeking medical clearance physical

examinations for athletic participation. In practicing the subject methods, any

individual desiring to participate in organized sports is provided the opportunity,

means and devices to provide expanded data for present invention’s capability to

detect cardiac abnormalities. Invention’s unique methods and devices provide a

‘cost permissible’ means to gather data from athletes and integrally communicate

the input and output with software and devices provided with the device and

system. A means is provided for said data to be gathered and analyzed, inclusive of

athlete’s acoustical heart sounds, electrocardiograph signals and or echocardiogram

information. Present invention provides the means to record and analyze output

and input data to detect cardiac abnormalities utilizing system’s comparison

libraries. Additionally, by methods unique to present invention, software and

hardware are provided to ‘further’ enhance detection of underlying cardiac

abnormalities in athletes by simultaneously comparing acoustical, cardiac electrical

signals and echocardiogram information relationships in spatial and chronological

parameters to present invention’s reference libraries provided here within. Another

means unique to present invention is a scoring criterion applied to gathered and

analyzed data permitting an objective means to establish a novel ‘determinant’ for

coordinated recommendations and guidelines for all providers granting medical

clearance examinations, as example. Present invention will be shown to be a

solution to the previously cost prohibitive comprehensive cardiac screening

necessary to adequately detect underlying cardiac disorders in individuals of all

ages.

Pag

e13

5. REVOLUTIONARY SUMMATION EKG TECHNOLOGIES

BRIEF ABSTRACT:

Benefits: Revolutionizes conventional electrocardiogram signal detection and

clinical interpretation, integrates A.I. analysis resulting in more accurate diagnosis

while providing a globally responsive networked support system to modernize

conventional diagnostic libraries.

Technology: Proprietary, patent pending electrocardiogram system, software, and


Market Impact: Estimate $2-5 billion per year

Industry Insights:

Pag

e14

The cardiology market consists of cardiac assist devices, cardiac prosthetic

devices, cardiac rhythm management (CRM), cardiovascular monitoring and

diagnostic devices, cardiovascular surgical devices, electrophysiology, and

interventional cardiology.

With its $54.2 billion market opportunity by 2020, cardiology presents an

attractive target for non-traditional MedTech players—if they can offer high-

impact solutions supported by credible evidence has the potential to disrupt

traditional clinical research models.



EXPANDED ABSTRACT:

The present invention provides for methods and devices for a trained individual to

detect gather and transmit for analysis; the physiological cardiac emissions of a

mammal. In practicing the subject method(s), trained individuals are provided a

novel apparatus that is temporarily introduced into the esophagus of a mammal

wherein inventor’s apparatus comprises a series of inflatable elastomeric sensors

and electrodes integrally configured onto the outer surface of a longitudinal tubular

component wherein a vertical axis electrode and sensor array is provided. With the

cooperation of related submissions of inventor(s), a horizontal sensor array

apparatus is situated tangentially across the chest wall of said mammal wherein the

plurality and integration of invention’s components; as a system, provide a multi-

planar temporal relationship of sensors and electrodes in the x, y, and z planes.

Software unique to present invention permits user(s) to detect electrical, acoustical

and ultrasound information from a mammal’s cardiac emissions in a multitude of

manners novel to the applied field(s) of medicine. Present invention’s unique

methods and devices provide significant advancements over conventional cardiac

diagnostic modalities in regard to sensitivity and specificity of cardiac disorders

and additionally, through present invention’s means for coordinating transmission

of data through networks provided herein, a global database can be created to

encourage continual improvements and system learning features significantly

advantageous to the healthcare industry. Such applications of petitioned invention

to be integrated with Artificial Intelligence interpretations.

Pag

e15

6. VARIABLE FREQUENCY UV LIGHT STERILIZATION

BRIEF ABSTRACT:

Benefits: Eliminates static and airborne pathogens using a non-toxic, non-

chemical, rapid, improved ultra-violet exposure system

Technology: Proprietary, patent pending technology utilizing variable cycle ultra-

violet light frequency modulation.


Industry Insights:

Transparency Market Research states that the global UV disinfection equipment

market was valued at US$1.62 bn in 2016 and is expected to be worth US$6.73 bn

by the end of 2025. During the forecast years of 2017 and 2025, the global market

Pag

e16

for UV disinfection equipment market is expected to register a CAGR of 17.40%.

The significant rise will be attributable to the process of disinfection used by UV

disinfection technology that leaves behind no disinfection by-products.

Furthermore, the cost-effective nature of this technology to ensure end-to-end

cleaning is also winning the market for UV disinfection equipment tremendous

popularity.



EXPANDED ABSTRACT:

Means, methodology and devices are provided for incapacitating airborne life

forms; with or without potential properties of pathogenicity, in specific designated

arenas by the use of either pre calculated fixed frequency, variable interval

frequency, and or predetermined oscillating varying frequency ranges of UV light

radiation. Methods and devices are provided to incapacitate, to a desired degree of

efficacy, the survivability and pathogenic potential of micro and macro airborne

life forms in specific locations wherein airborne contact with any portion of a

mammal with said potentially pathogenic organisms may cause disease to said

portion or entity of a mammal as a whole. In practicing the subject methods,

present invention devices utilizing ultraviolet light generators; specifically those

emitting ranges of UV-A, UV-B, and UV-C light radiation; such as permitted with

mercury bulb generator sources; for example, are incorporated and configured to

be temporarily or permanently housed in specific pertinent atmospheric arenas. An

example of such pertinent arena could be the atmospheric environment within

health care facilities.

The current invention is designed to emit varying ranges of UV light emissions in

fixed wavelengths, varying wavelengths, and or harmonically oscillating

ultraviolet radiation to a determined atmospheric volume. Present invention design

permits function in a single mode or any combination of said alternatives

designated by inventors as Harmonic and Non-Harmonic Phases.

Alternative embodiments of the present invention are provided using adjunctive

cooperation with sound wave frequencies and directional ultrasonic coupling of

said sound wave frequencies to prevent damage to sensitive equipment and

encourage continual improvements and artificial intelligence system learning

features significantly advantageous to the healthcare industry.

Pag

e17

7. SUMMATION TECHNOLOGIES APPLIED TO

PHYSIOLOGIC DATA DETECTION

BRIEF ABSTRACT:

Benefits: Allows for rapid and accurate health assessments with complete

physiological data presented with A.I. assessment for precise diagnosis.

Technology: Proprietary, patent pending monitoring system, software, and


Market Impact: Estimate $2 billion per year

Industry Insights:

The global clinical laboratory tests market size was valued at USD 165.48 billion

in 2018. It is expected to expand at a CAGR of 7.1% during the forecast period.

Rise in prevalence of chronic disorders along with heightened awareness among

health-conscious people has encouraged the growth of the market.


Pag

e18


EXPANDED ABSTRACT:

An Intercalated System of integrated and cooperative Methods, Devices and

Software is provided to identify, interpret, analyze, store and remotely transfer

physiologic data from a mammal. Input and output data may be individually and or

simultaneously and cooperatively integrated and compared in invention’s novel

summation format and software permitting a significantly enhanced sensitivity and

specificity in identification of specific abnormalities and disorders of a mammal.

Such integrated and simultaneous comparison of certain physiologic parameters

will significantly advance Health Care Specialists’ ability to detect underlying

cardiac abnormalities. For example, detect symptoms that were undetectable with

prior art and science, and give new understanding as to which identified

abnormalities are clinically significant. Invention provides a means to develop and

create new diagnostic scoring criterion to be utilized and expanded on in the fields

of Cardiology, Critical Care and Emergency Medicine; to name a few, both in the

acute and critical phase as well as with routine testing. Extrapolated data provided

by methods and software here within will be utilized to create novel databases and

libraries of clinical determinations of normal, normal variance and or significant

abnormalities which will greatly assist health care providers’ diagnostic abilities

and acuity.

Pag

e19

8. FEMININE HYGIENE TECHNOLOGIES

BRIEF ABSTRACT:

Benefits: Provides novel means for feminine hygiene, reduces potential infections

and eliminates the environmental risks attached with the disposal of conventional

feminine hygiene products.

Technology: Proprietary, patent pending, chemical free system designs


Industry Insights:

Global Feminine Hygiene Market was valued approximately USD 21.8 billion in

2016 is anticipated to grow with a healthy growth rate of more than 3.47% over the

forecast period 2017-2025. Global Feminine Hygiene Market is expected to reach

USD 44.3 billion by 2025. Growth in the organized retail market and rapid

urbanization are a reason for the rising demand for organic products These are

some of the factors that are driving the global feminine hygiene products market.

Despite these factors, the market is restrained by the environmental risks attached

with the disposal of most feminine hygiene products like sanitary pads and

tampons.

Development Stage: Prototype, engineered, tested.


EXPANDED ABSTRACT:

The petitioned inventions provide for methods and devices for an individual to

cleanse the internal intraluminal mucosal cavities and or external genitalia. The

novel devices are provided for an individual to discreetly and rapidly perform

personal hygiene cleansing of their genitalia and or the genitalia of other

individual(s) including; but not limited to, the vaginal vault and vulva, perineum

and perianal area, anus and rectal chamber, pubic mons and groin region, and or

any portion of an individual’s penis and scrotum. The present invention may also

provide a means of introducing internally and or externally, a variety of solutions

with varying properties to be utilized for purposes such as; but not limited to:

spermicidal agents, water, soaps, glycerin, mineral oil, antimicrobials, antifungal

agents, antiviral agents, hormones, medicines, PH buffering agents, deodorant

agents, other lubricating agents, aroma agents and or any combination of said

agents. Present inventions provide said functions by means of a novel hygienic

device with a plurality of components. Present invention is additionally

inexpensive, dispensable, and biodegradable and intended for a one-time use.

Pag

e20

9. BIOPHASIC SENSORY STIMULATION TECHNOLOGIES

BRIEF ABSTRACT:

Benefits: Devices and technologies providing novel treatment modalities in a

variety of medical fields such as pain management, collagen stimulation, wound

and bone healing, edema, migraines, seizures, concentration as well as natural

athletic performance enhancement and addiction management, for example.

Technology: Proprietary, patent pending system, software, and protocol.

Market Impact: Estimate $3-5 billion per year

Development Stage: Prototype, engineered, tested


EXPANDED ABSTRACT:

The petitioned technologies provide a revolutionary biophasic sensory stimulation

modality wherein various systems of a mammal react in such a manner previously

unutilized in modern medicine. Such breakthrough technology provides a

disruptive novel means and methodology for applied medicine to integrate the

Pag

e21

petitioned stimulatory devices in virtually every field of science and medicine. Our

proprietary technology will potentially provide a paradigm shift in treatment

applications and adjuncts such as acute and chronic pain management, wound and

bone healing, collagen formation, edema treatment, vascular insufficiency,

migraine headache control, seizure prevention and abatement, natural athletic

performance enhancement and recovery, concentration and recall, biofeedback and

relaxation and addiction management, for example.

10. INFANT ENVIRONMENT TECHNOLOGIES

BRIEF ABSTRACT:

Benefit: Prevention of infant deaths from preventable causes while in a crib, while

providing a controlled stimulus environment that enhances both the psychological

and physical health of infants. Technology: Dynamic controlled atmosphere,

sensory mattresses and linens, A.I. guided software, and advanced monitoring

systems ties to a responsive networked support system.

Market Impact: $200 million per year

Pag

e22

Industry Insights:

The global baby product market size was valued at USD 10.91 billion in 2017 and

is expected to register a CAGR of 5.5% over the forecast period on account of

rising spending capability and changing lifestyles. Rapid urbanization and growing

middle-class population across several developing regions are driving the market

further. Changing lifestyle, particularly in developing countries, has encouraged

the adoption of convenience-oriented routine, making these items desirable, which

will fuel the industry growth over the forecast period.


Time to Market: 3 - 5 years

EXPANDED ABSTRACT:

Vertu Medical provides comprehensive and patent petitioned proprietary means

and methods for the prevention of adverse outcomes in the infant and early

childhood years. Through years of dedicated research and investigations our

proprietary innovations and technologies will soon serve to reduce, if not

eliminate, preventable causes of sudden infant death syndrome and other well

documented adverse outcomes encountered with neonates. Our vast network of

providers, with decades of experience in the related fields, have come together to

compile a comprehensive portfolio of solutions and technologies addressing every

known potential adverse outcome for babies in the crib stage of life.